1. Australian Diabetes Society and New Zealand Society for the Study of Diabetes. ALERT UPDATE. Periprocedural Diabetic ketoacidosis (DKA) with SGLT2 inhibitor Use in People with Diabetes. 2022. https://www.diabetessociety.com.au/downloads/20220726%20ADS%20ADEA%20ANZCA%20NZSSD_DKA_SGLT2i_Alert_Ver%20July%202022.pdf
2. 11. Kuwajerwala, NK , Schwer, WA. Perioperative Medication Management. Medscape; 2018. https://emedicine.medscape.com/article/284801-overview
3. NSW Clinical Excellence Commission. Guidelines on perioperative management of anticoagulant and antiplatelet agents. 2018. https://www.cec.health.nsw.gov.au/__data/assets/pdf_file/0006/458988/Guidelines-on-perioperative-management-of-anticoagulant-and-antiplatelet-agents.pdf
4. Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis